284 related articles for article (PubMed ID: 8743512)
1. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
[TBL] [Abstract][Full Text] [Related]
2. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
Lenz T; August P
Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
[TBL] [Abstract][Full Text] [Related]
3. Nephroprotection by antihypertensive agents.
Schmieder RE
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
[TBL] [Abstract][Full Text] [Related]
4. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
Guidi E; Minetti EE; Cozzi MG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):40-5. PubMed ID: 11984747
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
6. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure and progression of renal failure in the elderly.
Acone D; Cante D; Cillo F; Giordano G; Giordano C
Kidney Int Suppl; 1996 Jun; 55():S75-7. PubMed ID: 8743516
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?
Giverhaug T; Falck A; Eriksen BO
J Hum Hypertens; 2004 Sep; 18(9):649-54. PubMed ID: 15002005
[TBL] [Abstract][Full Text] [Related]
9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
10. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(11):231-4; discussion 234-5. PubMed ID: 8928521
[TBL] [Abstract][Full Text] [Related]
11. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
Vogt L; Kocks MJ; Laverman GD; Navis G
Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of outpatient renoprotective therapy].
Kolina IB; Stavrovskaia EV; Shilov EM
Ter Arkh; 2005; 77(6):33-5. PubMed ID: 16078597
[TBL] [Abstract][Full Text] [Related]
13. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
[TBL] [Abstract][Full Text] [Related]
15. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline?
van Essen GG; Apperloo AJ; Rensma PL; Stegeman CA; Sluiter WJ; de Zeeuw D; de Jong PE
Kidney Int Suppl; 1997 Dec; 63():S58-62. PubMed ID: 9407423
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
Björck S; Aurell M
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
[TBL] [Abstract][Full Text] [Related]
17. [Use of angiotensin-converting enzyme inhibitors in chronic kidney insufficiency].
Kutyrina IM; Lifshits NL; Rogov VA; Kamyshova ES; Shvetsov MIu; Okonova EB; Androsova SO; Martynov SA; Miroshnichenko NG; Gerasimenko OI
Ter Arkh; 2002; 74(6):34-9. PubMed ID: 12136480
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
19. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
Kohzuki M; Kanazawa M; Liu PF; Kamimoto M; Yoshida K; Saito T; Yasujima M; Sato T; Abe K
J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
